Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individuals.

Hu KQ, Cui W, Rouster SD, Sherman KE.

World J Hepatol. 2019 May 27;11(5):442-449. doi: 10.4254/wjh.v11.i5.442.

2.

Zika virus replication and cytopathic effects in liver cells.

Sherman KE, Rouster SD, Kong LX, Aliota MT, Blackard JT, Dean GE.

PLoS One. 2019 Mar 20;14(3):e0214016. doi: 10.1371/journal.pone.0214016. eCollection 2019.

3.

HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles.

Shata MTM, Abdel-Hameed EA, Rouster SD, Yu L, Liang M, Song E, Esser MT, Shire N, Sherman KE.

Pathog Immun. 2019;4(1):39-65. doi: 10.20411/pai.v4i1.267. Epub 2019 Feb 13.

4.

Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade.

Sherman KE, Abdel-Hameed E, Rouster SD, Shata MTM, Blackard JT, Safaie P, Kroner B, Preiss L, Horn PS, Kottilil S.

Clin Infect Dis. 2019 May 17;68(11):1911-1918. doi: 10.1093/cid/ciy807.

PMID:
30239650
5.

PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.

Sherman KE, Rouster SD, Kang M, Umbleja T, Sterling R, Butt AA; ACTG 5294 BIRTH Study Team.

Dig Dis Sci. 2018 Nov;63(11):2969-2974. doi: 10.1007/s10620-018-5278-y. Epub 2018 Sep 14.

PMID:
30218427
6.

Zika Virus Exposure in an HIV-Infected Cohort in Ghana.

Sherman KE, Rouster SD, Kong LX, Shata TM, Archampong T, Kwara A, Aliota MT, Blackard JT.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):e35-e38. doi: 10.1097/QAI.0000000000001718. No abstract available.

7.

Hepatitis D diagnostics:Utilization and testing in the United States.

Safaie P, Razeghi S, Rouster SD, Privitera I, Sherman KE.

Virus Res. 2018 May 2;250:114-117. doi: 10.1016/j.virusres.2018.03.013. Epub 2018 Mar 27.

PMID:
29596839
8.

Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients.

Abdel-Hameed EA, Rouster SD, Boyce CL, Zhang X, Biesiada J, Medvedovic M, Sherman KE.

Dig Dis Sci. 2018 Mar;63(3):645-652. doi: 10.1007/s10620-017-4895-1. Epub 2018 Jan 12.

PMID:
29330726
9.

Characterization of HCV NS3 Protease Variants in HCV/HIV-Coinfected Patients by Ultra-Deep Sequence Analysis: Relationship with Hepatic Fibrosis.

Abdel-Hameed EA, Rouster SD, Zhang X, Chen J, Medvedovic M, Goodman ZD, Sherman KE.

J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):353-358. doi: 10.1097/QAI.0000000000001256.

10.

Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.

Mehta M, Hetta HF, Abdel-Hameed EA, Rouster SD, Hossain M, Mekky MA, Khalil NK, Mohamed WA, El-Feky MA, Ahmed SH, Daef EA, El-Mokhtar MA, Abdelwahab SF, Medhat A, Sherman KE, Shata MT.

Arch Virol. 2016 Nov;161(11):3161-9. doi: 10.1007/s00705-016-3015-4. Epub 2016 Aug 20.

11.

Viral dynamic modelling of Hepatitis C and resistance-associated variants in haemophiliacs.

Sherman KE, Ke R, Rouster SD, Abdel-Hameed EA, Park C, Palascak J, Perelson AS.

Haemophilia. 2016 Jul;22(4):543-8. doi: 10.1111/hae.12918. Epub 2016 Mar 3.

12.

Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department.

Lyons MS, Kunnathur VA, Rouster SD, Hart KW, Sperling MI, Fichtenbaum CJ, Sherman KE.

Clin Infect Dis. 2016 May 1;62(9):1066-71. doi: 10.1093/cid/ciw073. Epub 2016 Feb 21.

13.

Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy.

Abdel-Hameed EA, Rouster SD, Ji H, Ulm A, Hetta HF, Anwar N, Sherman KE, Shata MT.

Viral Immunol. 2016 May;29(4):252-8. doi: 10.1089/vim.2015.0093. Epub 2016 Feb 17.

14.

Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients.

Sherman KE, Guedj J, Shata MT, Blackard JT, Rouster SD, Castro M, Feinberg J, Sterling RK, Goodman Z, Aronow BJ, Perelson AS.

Sci Transl Med. 2014 Jul 23;6(246):246ra98. doi: 10.1126/scitranslmed.3008195.

15.

Hepatitis E infection in HIV-infected liver and kidney transplant candidates.

Sherman KE, Terrault N, Barin B, Rouster SD, Shata MT; HIV-TR Investigators.

J Viral Hepat. 2014 Aug;21(8):e74-7. doi: 10.1111/jvh.12233. Epub 2014 Apr 28.

16.

Hepatitis C virus NS3 mutations in haemophiliacs.

Lin MV, Charlton AN, Rouster SD, Zamor PJ, Sherman KE.

Haemophilia. 2014 Sep;20(5):659-65. doi: 10.1111/hae.12420. Epub 2014 Apr 3.

17.

Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro.

Martin CM, Welge JA, Rouster SD, Shata MT, Sherman KE, Blackard JT.

J Viral Hepat. 2012 Oct;19(10):716-23. doi: 10.1111/j.1365-2893.2012.01595.x. Epub 2012 Jun 4.

18.

HIV variability in the liver and evidence of possible compartmentalization.

Blackard JT, Ma G, Martin CM, Rouster SD, Shata MT, Sherman KE.

AIDS Res Hum Retroviruses. 2011 Oct;27(10):1117-26. doi: 10.1089/AID.2010.0329. Epub 2011 May 4.

19.

Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.

Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RT; AIDS Clinical Trials Group 5071 Study Team.

J Infect Dis. 2010 Mar;201(5):712-9. doi: 10.1086/650490.

20.

Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.

Martin CM, Welge JA, Shire NJ, Rouster SD, Shata MT, Sherman KE, Blackard JT.

J Viral Hepat. 2010 Aug;17(8):588-97. doi: 10.1111/j.1365-2893.2009.01214.x. Epub 2009 Nov 2.

21.

Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt.

Blackard JT, Rouster SD, Nady S, Galal G, Marzuuk N, Rafaat MM, Daef E, El Din SS, Purcell RH, Emerson SU, Sherman KE, Shata MT.

J Clin Virol. 2009 Oct;46(2):140-4. doi: 10.1016/j.jcv.2009.07.007. Epub 2009 Aug 3.

22.

Hepatitis E virus antibodies in patients with chronic liver disease.

Atiq M, Shire NJ, Barrett A, Rouster SD, Sherman KE, Shata MT.

Emerg Infect Dis. 2009 Mar;15(3):479-81. doi: 10.3201/eid1503.080740.

23.

The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.

Shire NJ, Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ, Sherman KE.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):309-14.

PMID:
17159656
24.

HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.

Shire NJ, Horn PS, Rouster SD, Stanford S, Eyster ME, Sherman KE; Multicenter Hemophilia Cohort HCV Study Group.

Hepatology. 2006 Nov;44(5):1146-57.

PMID:
17058240
25.

Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.

Sherman KE, Shire NJ, Cernohous P, Rouster SD, Omachi JH, Brun S, Da Silva B.

Clin Infect Dis. 2005 Oct 15;41(8):1186-95. Epub 2005 Sep 13.

PMID:
16163639
26.

Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.

Sherman KE, Shire NJ, Rouster SD, Peters MG, James Koziel M, Chung RT, Horn PS.

Gastroenterology. 2005 Feb;128(2):313-27.

27.

HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV.

Qin H, Shire NJ, Keenan ED, Rouster SD, Eyster ME, Goedert JJ, Koziel MJ, Sherman KE; Multicenter Hemophilia Cohort Study Group.

Blood. 2005 Jan 15;105(2):533-41. Epub 2004 Sep 16.

28.

Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea.

Morelli MS, Rouster SD, Giannella RA, Sherman KE.

Clin Gastroenterol Hepatol. 2004 Aug;2(8):669-74.

PMID:
15290659
29.

Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain.

Keenan ED, Rouster SD, Shire NJ, Horn PS, Sherman KE.

J Infect Dis. 2004 Aug 1;190(3):511-4. Epub 2004 Jul 7.

PMID:
15243925
30.

Occult hepatitis B in HIV-infected patients.

Shire NJ, Rouster SD, Rajicic N, Sherman KE.

J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):869-75.

PMID:
15213572
31.

Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus.

Sherman KE, Rouster SD, Horn PS.

Clin Infect Dis. 2002 Aug 15;35(4):482-7. Epub 2002 Jul 22.

PMID:
12145734
32.

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.

Sherman KE, Rouster SD, Chung RT, Rajicic N.

Clin Infect Dis. 2002 Mar 15;34(6):831-7. Epub 2002 Feb 6.

PMID:
11833007
33.

Prevalence and genotypic variability of TTV in HIV-infected patients.

Sherman KE, Rouster SD, Feinberg J.

Dig Dis Sci. 2001 Nov;46(11):2401-7.

PMID:
11713943
34.

Mechanism of indinavir-induced hyperbilirubinemia.

Zucker SD, Qin X, Rouster SD, Yu F, Green RM, Keshavan P, Feinberg J, Sherman KE.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12671-6. Epub 2001 Oct 16.

35.

Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease.

Sherman KE, Rouster SD, Mendenhall C, Thee D.

Hepatology. 1999 Jul;30(1):265-70.

PMID:
10385665
36.

Host response to mycobacterial infection in the alcoholic rat: male and female dimorphism.

Li X, Grossman CJ, Mendenhall CL, Hurtubise P, Rouster SD, Roselle GA, Gartside P.

Alcohol. 1998 Oct;16(3):207-12.

PMID:
9744851
37.

Hepatitis C serotypes in nonalcoholic and alcoholic patients.

Sherman KE, Mendenhall C, Thee DL, O'Brien J, Rouster SD.

Dig Dis Sci. 1997 Nov;42(11):2285-91.

PMID:
9398807
38.

Biphasic in vivo immune function after low- versus high-dose alcohol consumption.

Mendenhall CL, Theus SA, Roselle GA, Grossman CJ, Rouster SD.

Alcohol. 1997 May-Jun;14(3):255-60.

PMID:
9160803
39.

Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in alpha-fetoprotein. Department of Veterans Affairs Cooperative Study Group 275.

Mendenhall CL, Roos F, Moritz TE, Roselle GA, Chedid A, Grossman CJ, Rouster SD, Bennett GL, Lake JR.

Alcohol Clin Exp Res. 1996 Dec;20(9):1625-30.

PMID:
8986214
40.

The impact of age on alcohol toxicity in the rat.

Mendenhall CL, Rouster SD, Grossman CJ, Roselle GA, Ghosn S, Gartside P.

Alcohol Alcohol. 1993 Nov;28(6):675-85.

PMID:
7908525
41.

Impact of chronic alcoholism on the aging rat: changes in nutrition, liver composition, and mortality.

Mendenhall CL, Rouster SD, Roselle GA, Grossman CJ, Ghosn S, Gartside P.

Alcohol Clin Exp Res. 1993 Aug;17(4):847-53.

PMID:
8214425
42.

Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease.

Hertelendy ZI, Mendenhall CL, Rouster SD, Marshall L, Weesner R.

Am J Gastroenterol. 1993 May;88(5):737-43.

PMID:
8480740
43.

Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119)

Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, Rouster SD, Buskell-Bales Z, Grossman CJ, Roselle GA, et al.

Hepatology. 1991 Oct;14(4 Pt 1):581-9.

PMID:
1655605
44.

Host response to mycobacterial infection in the alcoholic rat.

Mendenhall CL, Grossman CJ, Roselle GA, Ghosn S, Gartside PS, Rouster SD, Chalasani PV, Schmitt G, Martin K, Lamping K.

Gastroenterology. 1990 Dec;99(6):1723-6.

PMID:
2227286
45.

False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis.

Mendenhall CL, Roselle GA, Grossman CJ, Rouster SD, Weesner RE.

N Engl J Med. 1986 Apr 3;314(14):921-2. No abstract available.

PMID:
3513019
46.

Incorporation of the spin trap DMPO into cultured fetal mouse liver cells.

Morgan DD, Mendenhall CL, Bobst AM, Rouster SD.

Photochem Photobiol. 1985 Jul;42(1):93-4. No abstract available.

PMID:
4059359

Supplemental Content

Loading ...
Support Center